Register for our S/EIS Fund

In this ChaiTime chaired by Prashant Shah, we will be taking a behind the scenes look at the transition from deep science research to CEO. Away from the polished pitches we will be asking these recent CEO’s for their candid views on the journey and pains that characterize leading a company to market success.

The panelists
Myriam Ouberai Founder and CEO at Spirea

Myriam Ouberai is the Founder and CEO of Spirea with a PhD in Chemistry and has significant experience in drug delivery and biopharmaceuticals in both academia and industry. She was previously a Senior Postdoctoral Research Associate at the University of Cambridge, Nanoscience Centre

William Bateman Founder and CEO at CCell Renewables Ltd

William is the innovator behind Zyba, a clean-tech company focused on delivering marine renewable energy & growing artificial coral reefs. CCell stems from his PhD on the numerical modelling of extreme ocean waves from Imperial College London.

Oliver Armitage Co-founder and CSO at Bios Health

Oliver has always had a vision that the human body could be repaired or made better through augmentative technology. He studied for his PhD at the University of Cambridge in Bioengineering and specializes in tissue interfaces & engineering to allow technology to be fused with the body. Oliver was named to Forbes 30 Under 30 2018.

Fiona Neilsen CEO at o2h technology

Fiona Nielsen brings 20 years of experience in the Technology and life science industry. With a background in computer science combined with her degree in Bioinformatics Fiona arrived in Cambridge, UK, to work for deep-tech life science company Illumina before emerging as an entrepreneur in genomics and life science.

Prashant Shah Executive Chairman at o2h group

Register for Invitations